The Trump administration intends to enforce a new testing requirement for vaccines, necessitating testing against a placebo, which may delay COVID-19 vaccine availability. This shift, described as a radical change from previous protocols, has alarmed vaccine experts who caution that it could diminish public trust in vaccines. Critics argue that this move by Robert F. Kennedy Jr. reflects his anti-vaccine stance and could complicate the approval process for various vaccines, despite assurances from the administration that it aims to enhance vaccine safety through greater transparency.
"I think it is the interest of Robert F. Kennedy Jr. to make vaccines more expensive, less available and more feared," said Dr. Paul Offit.
"Secretary Kennedy's HHS has pledged radical transparency... about medical products, including vaccines," Nixon said.
Collection
[
|
...
]